Top Health Care companies in United Kingdom by Cash and Short-Term Investments

This ranking features the top 66 Health Care companies in United Kingdom ranked by Cash and Short-Term Investments, totaling a Cash and Short-Term Investments of USD 23.41 B, for June 20, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2

Frequently Asked Questions

Which Health Care company in United Kingdom has the highest Cash and Short-Term Investments ?

The Health Care company in United Kingdom with the highest Cash and Short-Term Investments is AstraZeneca PLC (LSE: AZN.L) at USD 5.53 B.
Which Health Care company in United Kingdom has the lowest Cash and Short-Term Investments ?

The Health Care company in United Kingdom with the lowest Cash and Short-Term Investments is genedrive plc (LSE: GDR.L) at None.

What are the top 10 Health Care companies in United Kingdom by Cash and Short-Term Investments ?

The top 10 Health Care companies in United Kingdom by Cash and Short-Term Investments are AstraZeneca PLC, Roivant Sciences Ltd., GSK plc, Haleon plc, Immunocore Holdings plc, Smith & Nephew plc, Smiths Group plc, Autolus Therapeutics plc, Centessa Pharmaceuticals plc and LivaNova PLC.
What are the bottom 10 Health Care companies in United Kingdom by Cash and Short-Term Investments ?

The bottom 10 Health Care companies in United Kingdom by Cash and Short-Term Investments are genedrive plc, Fusion Antibodies plc, Futura Medical plc, Bioventix PLC, Akari Therapeutics, Plc, Cizzle Biotechnology Holdings Plc, Feedback plc, Bicycle Therapeutics plc, Akanda Corp. and Hemogenyx Pharmaceuticals Plc.